Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Australia
/
Healthcare
Create a narrative
Next Science Community
ASX:NXS Community
1
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Next Science
Popular
Undervalued
Overvalued
Community Investing Ideas
Next Science
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
FDA Engagement And XPERIENCE Will Secure Future Confidence
Key Takeaways Strong growth in key products and a high gross margin suggest potential for future revenue and net margin improvement. Addressing the FDA warning could enhance market confidence and stability, benefiting future earnings and stock valuation.
View narrative
AU$0.27
FV
65.8% undervalued
intrinsic discount
43.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
15 days ago
author updated this narrative
Your Valuation for
NXS
NXS
Next Science
Your Fair Value
AU$
Current Price
AU$0.092
91.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-16m
106m
2015
2018
2021
2024
2025
2027
2030
Revenue US$106.4m
Earnings US$15.3m
Advanced
Set Fair Value